Deadline next week: berger montague advises regeneron pharmaceuticals, inc. (nasdaq: regn) investors to contact the firm before march 10, 2025

Philadelphia, march 03, 2025 (globe newswire) -- nationally recognized law firm berger montague pc informs investors that a lawsuit was filed against regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) on behalf of purchasers of regeneron securities between november 2, 2023 and october 30, 2024, inclusive (the “class period”).
REGN Ratings Summary
REGN Quant Ranking